NEVVI Medicare utilization intelligence
or

← back

Provider profile

WANG, ROBERT M.D.

Ophthalmology · NPI 1568447175 · DALLAS, TX

1
Groups
26
Codes · 2024
65,929
Disclosed services

WANG, ROBERT is a Ophthalmology in DALLAS, TX, a member of 1 medical group, who billed 26 distinct codes to Medicare Part B in 2024.

Groups: TEXAS RETINA ASSOCIATES (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

65,929
disclosed services
26
codes billed to Medicare Part B
Prior year · CY2023 74,847 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J2777 Injection, faricimab-svoa, 0.1 mg
J0177 Injection, aflibercept hd, 1 mg
92134 Imaging of retina
J2781 Injection, pegcetacoplan, intravitreal, 1 mg
67028 Injection of drug into eye
J2782 Injection, avacincaptad pegol, 0.1 mg
92012 Established patient problem focused exam of visual system
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg
J3299 Injection, triamcinolone acetonide (xipere), 1 mg
92014 Established patient complete exam of visual system
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
92004 New patient complete exam of visual system
92235 Exam of retinal blood vessels using a special camera after injection of a dye
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J3490 Unclassified drugs
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J0178 Injection, aflibercept, 1 mg
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
67036 Removal of eye fluid (vitreous) between lens and retina
67042 Removal of membrane of retina with removal of internal limiting membrane of retina
67516 Injection of drug into the space between the cornea and retina in the eye
92273 Measurement of retinal and optic nerve function
92274 Measurement of retinal and optic nerve function targeting multiple separate locations
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
67041 Removal of membrane of retina

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.